Home
Conditions
Myelodysplastic-Myeloproliferative Diseases

Clinical trial condition

Myelodysplastic-Myeloproliferative Diseases

Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.

155 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic-Myeloproliferative Diseases trial results

Completed

Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer

NCT00014495

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +26 more
Locations: Memorial Sloan - Kettering Cancer Center New York, United States

View Trial Details

Completed

T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia

NCT00002718

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +26 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer

NCT00028730

Conditions: Bone Marrow Diseases, Burkitt Lymphoma, Chronic Disease, +31 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia

NCT00588809

Conditions: Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Promyelocytic Leukemia (M3), Bone Marrow Diseases, +13 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

NCT00716911

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
Locations: Not specified

View Trial Details

Completed

A Standardized Nursing Intervention Protocol for HCT Patients

NCT00951626

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Completed

Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer

NCT00019656

Conditions: Bone Marrow Diseases, Burkitt Lymphoma, Chronic Disease, +39 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

NCI - Center for Cancer Research Bethesda, Maryland, United States

View Trial Details

Completed

S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

NCT00919425

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +33 more
Locations: Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States

Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States

Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center Burbank, California, United States

Peninsula Medical Center Burlingame, California, United States

View all 292 locations

View Trial Details

Completed

S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

NCT00996047

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +42 more
Locations: Providence Cancer Center at Providence Hospital Mobile, Alabama, United States

Providence Cancer Center Anchorage, Alaska, United States

Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States

Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States

View all 280 locations

View Trial Details

Completed

INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease

NCT01164163

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +37 more
Locations: UAB Comprehensive Cancer Center Birmingham, Alabama, United States

Children's Hospital of Orange County Orange, California, United States

UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

Children's Hospital Colorado Center for Cancer and Blood Disorders Aurora, Colorado, United States

View all 24 locations

View Trial Details

Myelodysplastic-Myeloproliferative Diseases

Myelodysplastic-Myeloproliferative Diseases trial results

Related conditions